Kinin receptors in human vascular tissue: Their role in atheromatous disease

Immunopharmacology

Volumn 36, Issue 2-3, 1997, Pages 153-160

  Raidoo, Deshandra M ^a   Ramsaroop, Reena ^a   Naidoo, Strini ^a   Müller Esterl, Werner ^b   Bhoola, Kanti D ^a  

^a UNIVERSITY OF NATAL   (South Africa)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Atheromatous disease; Bradykinin B2 receptor; Confocal microscopy; Human blood vessels; Human vascular system; Immunocytochemistry; Kinin B1 receptor; Tissue kallikrein

Indexed keywords

BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; BRADYKININ RECEPTOR; KALLIKREIN;

AMINO ACID SEQUENCE; ANTIBODY LABELING; ARTERY; ATHEROMATOSIS; BLOOD VESSEL PERMEABILITY; CARDIOVASCULAR SYSTEM; CONFERENCE PAPER; CONFOCAL MICROSCOPY; ENDOTHELIUM CELL; FIBROBLAST; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; INFLAMMATORY CELL; INTIMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION; SMOOTH MUSCLE FIBER; TUNICA MEDIA; VASOCONSTRICTION;

AMINO ACID SEQUENCE; ANTIBODY SPECIFICITY; ARTERIES; ARTERIOLES; ARTERIOSCLEROSIS; AUTOPSY; CAPILLARY PERMEABILITY; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; KALLIKREINS; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; STAINING AND LABELING; TISSUE KALLIKREINS; VASOCONSTRICTOR AGENTS; VEINS;

EID: 0030803883     PISSN: 01623109     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0162-3109(97)00015-5     Document Type: Conference Paper

References (34)

1. Abelous, J.E., Bardier, E., 1909. Les substances hypertensives de l'urine humaine normale. C. R. Soc. Biol. Paris 66, 511-512.
2. Bhoola, K.D., 1996. Translocation of the neutrophil kinin moiety and changes in the regulation of kinin receptors in inflammation. Immunopharmacology 33, 247-256.
3. Burch, R.M., Axelrod, J., 1987. Dissociation of bradykinin-stimulated arachidonic acid and release from inositol phosphate formation in Swiss 3T3 fibroblasts. Evidence for G-protein regulation of phospholiphase A2. Proc. Natl. Acad. Sci. USA 84, 6374-6378.
4. Campos, A.M., Calixto, J.B., 1993. Mechanisms involved in the contractile responses of kinins in rat portal vein rings: Mediation by B1 and B2 receptors. J. Pharmacol. Exp. Ther. 268, 902-909.
5. Carretero, O.A., Scicli, A.C., 1991. Local hormonal factors (intracrine, autocrine and paracrine) in hypertension?. Hypertension 18, 58-69.
6. Carretero, O.A., Scicli, A.G., 1988. Kinins paracrine hormone. Kidney Int. 26 (Suppl.), S52-S59.
7. Costerousse, O., Jaspard, E., Wei, L., Corvol, P., Alhenc-Gelas, F., 1992. The angiotensin I-converting enzyme (kininase II): Molecular organisation and regulation of its expression in humans. J. Cardiovasc. Pharmacol. 20, S10-15.
8. Figueroa, C.D., Gonzales, C.B., Müller-Esterl, W., Bhoola, K.D., 1992. Cellular localisation of human kininogens. Agents Actions (Suppl. 1) 617-626.
9. Fitzgibbon, W.R., Ploth, D.W., Margolius, H.S., 1993. Kinins as vasoactive peptides. Curr. Opin. Nephrol. Hypertens. 2, 283-290.
10. Flemming, I., Hecker, M., Busse, R., 1994. Intracellular alkalinization induced by bradykinin sustains activation of the constitutive activation on nitric oxide synthase in endothelial cells. Circ. Res. 74, 1220-1226.
11. Forstermann, U., Mugge, A., Alheid, U., Haverich, A., Frolich, J.C., 1988. Selective attenuation of endothelium-mediated vasodilatation in atherosclerotic human coronary arteries. Circ. Res. 62, 185-190.
12. Haasemann, M., Figueroa, C.D., Henderson, L., Grigoriev, S., Abd Alia, S., Gonzalez, C.B., Dunia, I., Hoebeke, J., Janagin, K., Cartaud, J., Bhoola, K.D., Müller-Esterl, W., 1994. Distribution of bradykinin B2 receptors in target cells of kinin action. Visualisation of the receptor protein in A431 cells, neutrophils and kidney sections. Braz. J. Med. Biol. Res. 27, 1739-1756.
13. Johnstone, A., Thorpe, R., 1982. Purification of immunoglobulins, constituent chains and fragments. In: Immunochemistry in Practice, Blackwell Scientific Publications, Oxford, London, pp. 41-48.
14. Kaplan, A.P., Silverberg, M., 1987. The coagulation-kinin pathway. Blood 70, 1-15.
15. Lüchhoff, A., 1988. Release of prostacyclin and EDRF from endothelial cells is differentially controlled by extra and intracellular calcium. Eicosanoids 1, 5-11.
16. Madeddu, P., Gherli, T., Bacciu, P.P., Maioli, M., Glorioso, N., 1993. A kallikrein-like enzyme in human vascular tissue. Am. J. Hypertens. 6, 344-348.
17. Menke, J.G., Borkowski, J.A., Bierilo, K.K., MacNeil, T., Derrick, A.W., Schneck, K.A., Ransom, R.W., Strader, C.D., Linemeyer, D.L., Hess, J.F., 1994. Expression cloning of a human B1 bradykinin receptor. J. Biol. Chem. 269 (34), 21583-21586.
18. Mombouli, J.-V., Vanhoutte, P.M., 1992. Kinins mediate kallikrein-induced endothelium-dependent relaxations in isolated cananine coronary arteries. Biophys. Res. Commun. 185.
19. Mombouli, J.-V., Vanhoutte, P.M., 1995. Kinins and endothelial control of vascular smooth muscle. Annu. Rev. Pharmacol. Toxicol. 35, 679-705.
20. Naidoo, S., Ramsaroop, R., Naidoo, Y., Bhoola, K.D., 1996. The status of B2 receptors in acute renal transplant rejection. Immunopharmacology 33, 157-160.
21. Olesen, S.P., 1987. Regulation of ion permeability in frog brain venules, significance of calcium, cyclic nucleotides and protein kinase C. Can. J. Physiol. 387, 59-68.
22. Regoli, D., Barabé, J., 1980. Pharmacology of bradykinin and related kinins. Pharmacol. Rev. 32, 1-46.
23. Rett, K., Wicklmayr, M., Dietze, G.J., 1990. Metabolic effects of kinins: Historical and recent developments. J. Cardiovasc. Pharmacol. 15, 57-59.
24. Saed, G.M., Carretero, O.A., MacDonald, R.J., Scicli, A.G., 1990. Kallikrein messenger RNA in rat arteries and veins. Circ. Res. 67, 510-516, Circulation Research.
25. Schachter, M., Maranda, B., Moriwaki, C., 1978. Localisation of glandular kallikrein in the coagulating and submandibular glands of the guinea-pig. J. Histochem. Cytochem. 26, 318-321.
26. Schmaier, A.H., Kuo, A., Lundberg, D., Murray, S., Clines, D.B., 1988. The expression of high molecular weight kininogen in human umbilical vein endothelial cells. J. Biol. Chem. 263, 16327-16333.
27. Schremmer-Danninger, E., Öffner, A., Siebeck, M., Heinz-Erian, P., Gais, P., Roscher, A.A., 1996a. Autoradiographic visualisation of B1 bradykinin receptors in porcine vascular tissues in the presence or absence of inflammation. Immunopharmacology 33, 95-100.
28. Schremmer-Danninger, E., Öffner, A., Siebeck, M., Roscher, A.A., 1996b. B1 and B2 bradykinin receptors in porcine arterial vessels. Immunopharmacology, in press.
29. Shi, S.-R., Key, M.E., Kalra, K.L., 1991. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J. Histochem. Cytochem. 39, 741-748.
30. Shimamoto, K., Miura, T., Miki, T., Iimura, O., 1992. Activation of kinins on myocardial ischaemia. Agents Actions 38, 90-97.
31. Shimokawa, H., Flavahan, N.A., Vanhoutte, P.M., 1989. Prostacyclin releases endothelium-derived relaxing factor and potentiates its action in coronary arteries of the pig. Br. J. Pharmacol. 95, 1197-1203.
32. Simson, J.A.V., Condon, J., Fenters, R., Chao, L., Chao, J., 1988. Immunocytochemical localisation of a kallikrein-like serine protease (esterase A) in rat salivary glands. Anat. Rec. 221, 475-481.
33. van Iwaarden, F., de Groot, P.G., Sixma, J.J., Berretini, M., Bouma, B.N., 1988. High molecular weight kininogen is present in cultured human endothelial cells: Localisation, isolation and characterisation. Blood 71, 1268-1276.
34. Wiemer, G., Popp, R., Scholkens, B.A., Gogelein, H., 1994. Enhancement of cytosolic calcium, prostacyclin and nitric oxide by bradykinin and the ACE inhibitor ramiprilat in porcine brain capillary endothelial cells. Brain Res. 638, 261-266.